Form 4: Zimmer Biomet Executive Chad F. Phipps Reports Stock Transactions

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the acquisition and disposal of common stock and restricted stock units on March 1, 2024.

Summary

• On March 1, 2024, Chad F. Phipps, a Senior Vice President, General Counsel, and Secretary at Zimmer Biomet Holdings, Inc., engaged in transactions involving the company's stock.
• Phipps acquired 1,641 shares of common stock through the vesting of restricted stock units (RSUs).
• Simultaneously, Phipps disposed of 646 shares of common stock to satisfy tax withholding obligations related to the RSU vesting at a price of $124.28 per share.
• Following these transactions, Phipps beneficially owns 47,951 shares of Zimmer Biomet Holdings, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. These transactions are closely monitored by regulators and investors for any potential signs of insider trading or other improprieties.

Comparison to Industry Standards

• Form 4 filings are standard practice for executives at publicly traded companies like Zimmer Biomet, similar to filings made by executives at competitors such as Stryker (SYK) and Johnson & Johnson (JNJ).
• The reporting requirements are governed by Section 16(a) of the Securities Exchange Act of 1934, ensuring transparency in executive stock transactions across the industry.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
• The filing provides transparency to shareholders regarding executive stock ownership.

Key Dates